Cardioprotection beyond the guidelines: the SAFE trial results

Back

ESC Professional Premium Access

Cardioprotection beyond the guidelines: the SAFE trial results

Session: Cardiotoxicity of cancer therapies

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Doctor G. Barletta (Florence, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Giuseppe Barletta

Careggi University Hospital (AOUC), Florence (Italy)

0 follower

5 more presentations in this session

Mitochondrial dynamics and myocardial metabolism alterations during anthracycline-cardiotoxicity

Speaker: Miss A. Diaz-Guerra Priego (Madrid, ES)

Adult survivors of childhood cancer have significant levels of impaired cardiorespiratory fitness, inflammatory markers and poor quality of life outcomes

Speaker: Doctor C. McCune (Belfast, GB)

Establishment of an in vivo murine model of immune checkPoint inhibitors cardiotoxicity: emerging role of vascular permeability in pembrolizumab-induced cardiotoxicity.

Speaker: Doctor P. Efentakis (Athens, GR)

Association between vitamin D receptor gene polymorphism and cardiomyopathy in response to adriamycin treatment among breast cancer patients

Speaker: Miss R. Mokhtar (Cairo, EG)

Association between immune checkpoint inhibitors and heart failure hospitalizations: a population-based self-controlled case series

Speaker: Professor G. Tse (Hong Kong, CN)

Access the full session

Cardiotoxicity of cancer therapies

Speakers: Doctor G. Barletta, Miss A. Diaz-Guerra Priego, Doctor C. McCune, Doctor P. Efentakis, Miss R. Mokhtar...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources